1. Home
  2. LPAA vs SMTI Comparison

LPAA vs SMTI Comparison

Compare LPAA & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPAA
  • SMTI
  • Stock Information
  • Founded
  • LPAA 2024
  • SMTI 1982
  • Country
  • LPAA United States
  • SMTI United States
  • Employees
  • LPAA N/A
  • SMTI N/A
  • Industry
  • LPAA
  • SMTI Medical/Dental Instruments
  • Sector
  • LPAA
  • SMTI Health Care
  • Exchange
  • LPAA Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • LPAA 286.9M
  • SMTI 288.2M
  • IPO Year
  • LPAA 2024
  • SMTI N/A
  • Fundamental
  • Price
  • LPAA $10.02
  • SMTI $35.33
  • Analyst Decision
  • LPAA
  • SMTI Buy
  • Analyst Count
  • LPAA 0
  • SMTI 1
  • Target Price
  • LPAA N/A
  • SMTI $44.00
  • AVG Volume (30 Days)
  • LPAA 92.1K
  • SMTI 32.8K
  • Earning Date
  • LPAA 01-01-0001
  • SMTI 11-12-2024
  • Dividend Yield
  • LPAA N/A
  • SMTI N/A
  • EPS Growth
  • LPAA N/A
  • SMTI N/A
  • EPS
  • LPAA N/A
  • SMTI N/A
  • Revenue
  • LPAA N/A
  • SMTI $78,056,873.00
  • Revenue This Year
  • LPAA N/A
  • SMTI $29.95
  • Revenue Next Year
  • LPAA N/A
  • SMTI $19.68
  • P/E Ratio
  • LPAA N/A
  • SMTI N/A
  • Revenue Growth
  • LPAA N/A
  • SMTI 24.66
  • 52 Week Low
  • LPAA $9.66
  • SMTI $26.00
  • 52 Week High
  • LPAA $10.03
  • SMTI $43.25
  • Technical
  • Relative Strength Index (RSI)
  • LPAA N/A
  • SMTI 49.41
  • Support Level
  • LPAA N/A
  • SMTI $35.56
  • Resistance Level
  • LPAA N/A
  • SMTI $37.60
  • Average True Range (ATR)
  • LPAA 0.00
  • SMTI 1.92
  • MACD
  • LPAA 0.00
  • SMTI -0.27
  • Stochastic Oscillator
  • LPAA 0.00
  • SMTI 34.86

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: